Roche’s one more attempts on Alzheimer’s disease therapies

In the Alzheimer’s disease therapy market, Roche was known to recently start domestic clinical trials one after another. Since they are clinical trials after experiencing failures on the two drugs for clinical trials in the past, the company attracted attention of the industry.

On July 7, the total 4 products – one of them is alteration of formulation of an already commercialized product – wer...